Creating Tomorrow's Diagnostics
and Treatments

Learn more

Faculty by Area of Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease, with an emphasis on respiratory, immune and related diseases.

Search by Name, Specialty, Program, or Research.

Bioanalytical & Central Laboratory Services for Research

National Jewish Health Advanced Diagnostic Laboratories is a high-complexity, CLIA-certified laboratory with more than 50 years’ experience developing assays and performing preclinical and clinical testing. Learn more.

Tucker Medical Library

Quality information for healthcare, education and scientific research.
Learn more.

Technology Transfer

We accelerate the development of basic scientific research toward clinical application by identifying and protecting the institution's intellectual property and facilitating business partnerships for technology development, licensing, and commercialization. Learn more.


Clinical Trials

We conduct clinical trials for patients with asthma, allergy, COPD, eczema, ILD, cystic fibrosis and more. Search our clinical trials.

Do you have an egg allergy? Learn more about this trial

Clinical trial FAQ's

Research Administration and Support

National Jewish Health supports academic and research activities across the campus and at outside organizations, including the University of Colorado Denver. Learn more.


Weinberg Clinical Research Unit

The Weinberg Clinical Research Unit focuses primarily on respiratory conditions. We entered the 21st century as the only institution in the world dedicated exclusively to this research of allergy, asthma, COPD/emphysema and sleep disorders as well as immune and autoimmune conditions, such as rheumatoid arthritis and cystic fibrosis. Learn more.

Bookmark and Share

Recent Publications

Motivational enhancement to improve adherence to positive airway pressure in patients with obstructive sleep apnea: a randomized controlled trial. PubMed

γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation. PubMed

More publications.